Amy W Schulman Buys $300K of Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 12, 2026
Equity Position
26K sh
24,049 → 25,959
Equity Change
+7.9%
shares held after vs before
Insider Cluster
2 buying
within 30 days — view cluster
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Amy W Schulman CIK 0001438226 |
Director
|
Amy W Schulman at Alnylam Pharmaceuticals Inc
Full insider history
Bought (12 mo)
$299,526
Sold (12 mo)
—
More from this insider at Alnylam Pharmaceuticals Inc
| 2026-05-22 | Award | — | View |
| 2026-05-14 | Exercise | — | View |
| 2025-05-12 | Award | — | View |
| 2025-03-14 | Exercise | — | View |
| 2024-06-27 | Sell | -$2,040,000 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-09 | P - Purchase | 1,910 A | $156.82 | +$299,526 | 25,959 | Direct |
Related filings at Alnylam Pharmaceuticals Inc
Institutional Holders
13F holders · Sep 30, 2026
721
institutional managers reporting a position
Largest by reported value
- Capital World Investors $3.41B
- Fmr Llc $3.11B
- Black Rock, Inc. $2.72B
5%+ Holders · 13D/G
6 filers
Other insiders at Alnylam Pharmaceuticals Inc
GET /v1/forms/4/0001178670-26-000085
API docs
View Original SEC Filing